You have no items in your shopping cart.
Human SOST Protein, His Tag
Description
Images & Validation
−| Application Notes |
|---|
Key Properties
−| Expression System | HEK293 |
|---|---|
| Target | SOST |
| Reactivity | Human |
| Tag | N-6×His |
| Molecular Weight | 22.3 kDa |
| Expression Region | Gln 24 - Tyr 213 |
| Purity | 90% |
| Endotoxins | 1.0 EU per μg |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | -20°C to -70°C for 12 months in lyophilized state;. -70°C for 3 months under sterile conditions after reconstitution. For long term storage, the product should be stored at lyophilized state at -20°C or lower |
|---|---|
| Form/Appearance | Powder |
| Buffer/Preservatives | PBS, pH 7.4 |
| Disclaimer | For research use only |
Similar Products
−Recombinant Human SOST/Sclerostin Protein, Avi His Tag [orb1550393]
> 95% by Tris-Bis PAGE
Recombinant Human SOST/Sclerostin Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Gln24-Tyr213) of Human SOST/Sclerostin fused with a His Tag and Avi tag at the N-terminal.
100 μgRecombinant human SOST/Sclerostin Protein, His Tag [orb1551185]
> 95% by SDS-PAGE.
Recombinant human SOST/Sclerostin Protein is produced by HEK293 Cells expression system. The target protein is expressed with sequence (Gln24-Tyr213) of human SOST/Sclerostin (Accession #NP_079513.1) fused with a 8��His Tag at the N-terminus.
50 μg, 20 μgRecombinant Human SOST Protein, C-His [orb2834922]
>90% as determined by SDS-PAGE.
24.03 kDa
50 μg, 100 μg, 20 μgRecombinant Human SOST Protein, N-His-SUMO [orb2832517]
>90% as determined by SDS-PAGE.
34.04 kDa
100 μg, 20 μg, 50 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

SDS-PAGE analysis of Human SOST protein
Documents Download
Request a Document
Protocol Information
Wu, Y. et al. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling Eur Rev Med Pharmacol Sci, 21, 470-478 (2017)
Human SOST Protein, His Tag (orb257550)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review